📖
wiki page

gba-pd-consortium

📖 Wiki Page
institution1521 wordssynced 2026-04-02

GBA-PD Consortium

Overview

The GBA-PD Consortium is an international collaborative network dedicated to understanding and treating Parkinson's disease in individuals carrying mutations in the GBA1 (glucocerebrosidase) gene. Heterozygous GBA1 mutations are among the most significant genetic risk factors for Parkinson's disease, increasing risk by 5-6 fold in carriers.

Research Focus

Genetic Basis

  • GBA1 Gene: Encodes glucocerebrosidase, an enzyme that breaks down glucosylceramide
  • Mutation Types: Includes N370S, L444P, RecNciI, and other variants
  • Carrier Frequency: 5-10% of PD patients carry GBA1 mutations

Pathogenic Mechanisms

  • Lysosomal dysfunction leading to [alpha-synuclein](/proteins/alpha-synuclein) accumulation
  • Impaired [autophagy](/entities/autophagy) and mitochondrial dysfunction
  • Endoplasmic reticulum stress
  • Neuroinflammation pathways

Clinical Characteristics


GBA-PD typically presents with:
  • Earlier age of onset (mean ~55 years vs ~65 years for idiopathic PD)
  • Higher prevalence of non-motor symptoms
  • More rapid progression in some carriers
  • Increased risk of cognitive decline and dementia

Consortium Structure


...
📖 View canonical wiki page →
Related Entities
institutions-gba-pd-consortium
View on SciDEX ↗